Clinical trial

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

NCT00991926

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Orlistat Normalized identity: orlistatView linked drug · Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention normo-caloric diet Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2006-12-01

PhaseN/A

Conditions

Obesityverified · MONDO: obesity disorder

Interventions

OrlistatDRUG · verified · RxNorm: orlistat

normo-caloric dietOTHER

Sponsors & collaborators

Federico II Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00991926 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.